Patents by Inventor Raymond Luc

Raymond Luc has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240301358
    Abstract: An in vitro microfluidic intestine on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic intestinal cell culture, which is some embodiments is derived from patient's enteroids-derived cells, is described comprising L cells, allowing for interactions between L cells and gastrointestinal epithelial cells, endothelial cells and immune cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal autoimmune tissue, e.g., diabetes, obesity, intestinal insufficiency and other inflammatory gastrointestinal disorders. These multicellular-layered microfluidic intestine on-chips further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal duodenum, small intestinal jejunum, small intestinal ileum, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e.
    Type: Application
    Filed: March 12, 2024
    Publication date: September 12, 2024
    Inventors: Athanasia Apostolou, Antonio Varone, Magdalena Kasendra, Raymond Luc
  • Patent number: 12018284
    Abstract: An in vitro microfluidic intestine on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic intestinal cell culture, which is some embodiments is derived from patient's enteroids-derived cells, is described comprising L cells, allowing for interactions between L cells and gastrointestinal epithelial cells, endothelial cells and immune cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal autoimmune tissue, e.g., diabetes, obesity, intestinal insufficiency and other inflammatory gastrointestinal disorders. These multicellular-layered microfluidic intestine on-chips further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal duodenum, small intestinal jejunum, small intestinal ileum, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e.
    Type: Grant
    Filed: November 9, 2022
    Date of Patent: June 25, 2024
    Assignee: EMULATE, INC.
    Inventors: Athanasia Apostolou, Antonio Varone, Magdalena Kasendra, Raymond Luc
  • Publication number: 20230151333
    Abstract: An in vitro microfluidic intestine on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic intestinal cell culture, which is some embodiments is derived from patient's enteroids-derived cells, is described comprising L cells, allowing for interactions between L cells and gastrointestinal epithelial cells, endothelial cells and immune cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal autoimmune tissue, e.g., diabetes, obesity, intestinal insufficiency and other inflammatory gastrointestinal disorders. These multicellular-layered microfluidic intestine on-chips further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal duodenum, small intestinal jejunum, small intestinal ileum, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e.
    Type: Application
    Filed: November 9, 2022
    Publication date: May 18, 2023
    Inventors: Athanasia Apostolou, Antonio Varone, Magdalena Kasendra, Raymond Luc
  • Patent number: 11566231
    Abstract: An in vitro microfluidic intestine on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic intestinal cell culture, which is some embodiments is derived from patient's enteroids-derived cells, is described comprising L cells, allowing for interactions between L cells and gastrointestinal epithelial cells, endothelial cells and immune cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal autoimmune tissue, e.g., diabetes, obesity, intestinal insufficiency and other inflammatory gastrointestinal disorders. These multicellular-layered microfluidic intestine on-chips further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal duodenum, small intestinal jejunum, small intestinal ileum, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: January 31, 2023
    Assignee: EMULATE, INC.
    Inventors: Athanasia Apostolou, Antonio Varone, Magdalena Kasendra, Raymond Luc
  • Publication number: 20200283732
    Abstract: An in vitro microfluidic intestine on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic intestinal cell culture, which is some embodiments is derived from patient's enteroids-derived cells, is described comprising L cells, allowing for interactions between L cells and gastrointestinal epithelial cells, endothelial cells and immune cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal autoimmune tissue, e.g., diabetes, obesity, intestinal insufficiency and other inflammatory gastrointestinal disorders. These multicellular-layered microfluidic intestine on-chips further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal duodenum, small intestinal jejunum, small intestinal ileum, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e.
    Type: Application
    Filed: March 20, 2020
    Publication date: September 10, 2020
    Inventors: Athanasia Apostolou, Antonio Varone, Magdalena Kasendra, Raymond Luc
  • Patent number: 7115290
    Abstract: An improved process for the production of a hopped malt beer wherein a processing liquid containing riboflavin is hopped to form the desired beverage. The improvement comprises subjecting that processing liquid to an effective amount of actinic radiation of a wavelength adapted to decompose the riboflavin and thereby reduce the amount thereof, whereby a beer having enhanced light stability is obtained.
    Type: Grant
    Filed: October 10, 2003
    Date of Patent: October 3, 2006
    Assignee: Labatt Brewing Company Limited
    Inventors: Joseph Raymond Luc Bordeleau, David John Hastings, Michael Jerome McGarrity
  • Publication number: 20040076714
    Abstract: An improved process for the production of a hopped malt beer wherein a processing liquid containing riboflavin is hopped to form the desired beverage. The improvement comprises subjecting that processing liquid to an effective amount of actinic radiation of a wavelength adapted to decompose the riboflavin and thereby reduce the amount thereof, whereby a beer having enhanced light stability is obtained.
    Type: Application
    Filed: October 10, 2003
    Publication date: April 22, 2004
    Applicant: Labatt Brewing Company Limited
    Inventors: Joseph Raymond Luc Bordeleau, David John Hastings, Michael Jerome McGarrity
  • Patent number: 6649204
    Abstract: An improved process for the production of a hopped malt beer wherein a processing liquid containing riboflavin is hopped to form the desired beverage. The improvement comprises subjecting that processing liquid to an effective amount of actinic radiation of a wavelength adapted to decompose the riboflavin and thereby reduce the amount thereof, whereby a beer having enhanced light stability is obtained.
    Type: Grant
    Filed: September 17, 1999
    Date of Patent: November 18, 2003
    Assignee: Labatt Brewing Company Limited
    Inventors: Joseph Raymond Luc Bordeleau, David John Hastings, Micheal Jerome McGarrity
  • Patent number: 5811144
    Abstract: A process for the production of a hopped malt beer wherein a processing liquid containing riboflavin is hopped to form the desired beverage. The improvement comprises subjecting that processing liquid to an effective amount of actinic radiation of a wavelength adopted to decompose the riboflavin and thereby reduce the amount thereof, whereby a beer having enhanced light stability is obtained.
    Type: Grant
    Filed: November 29, 1996
    Date of Patent: September 22, 1998
    Assignee: Labatt Brewing Company Limited
    Inventors: Joseph Raymond Luc Bordeleau, David John Hastings, Michael Jerome McGarrity